Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence

@article{Andersson2004PharmacologyOT,
  title={Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence},
  author={K. Andersson and A. Wein},
  journal={Pharmacological Reviews},
  year={2004},
  volume={56},
  pages={581 - 631}
}
The lower urinary tract constitutes a functional unit controlled by a complex interplay between the central and peripheral nervous systems and local regulatory factors. In the adult, micturition is controlled by a spinobulbospinal reflex, which is under suprapontine control. Several central nervous system transmitters can modulate voiding, as well as, potentially, drugs affecting voiding; for example, noradrenaline, GABA, or dopamine receptors and mechanisms may be therapeutically useful… Expand
Therapeutic receptor targets for lower urinary tract dysfunction
Drug Influence on Lower Urinary Tract
Neural Mechanisms Underlying Lower Urinary Tract Dysfunction
Anatomy and physiology of the lower urinary tract.
Neurotrophins in the Lower Urinary Tract: Becoming of Age
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 797 REFERENCES
Pharmacology of the lower urinary tract.
The pharmacological treatment of urinary incontinence
Advances in the pharmacological control of the bladder
Influence of central serotonergic mechanisms on lower urinary tract function
Influence of central serotonergic mechanisms on lower urinary tract function.
Bladder activation: afferent mechanisms.
Current and future pharmacological treatment for overactive bladder.
Functional role of central muscarinic receptors for micturition in normal conscious rats.
The central control of micturition and continence: implications for urology
...
1
2
3
4
5
...